Current and emerging biomarkers in breast cancer: A revie

RR Kasar, KN Ahir - World Journal of Biology Pharmacy and Health …, 2024 - wjbphs.com
… We reviewed a number of imaging modalities in this review, … and is encoded by the ERBB2
gene [86,96]. Since HER2-positive … BRIP1 is a gene found on chromosome 17's long arm that …

Valproic acid and breast cancer: State of the art in 2021

A Wawruszak, M Halasa, E Okon, W Kukula-Koch… - Cancers, 2021 - mdpi.com
… This review focuses on in vitro and in vivo experimental data … status and level of development
of societies, cancer is one of … cancer cells without altering mRNAs levels of EGFR, ErbB2, …

[HTML][HTML] … , open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with …

MA Shah, D Cunningham, JP Metges… - … of cancer, 2021 - ncbi.nlm.nih.gov
… for stratification (PD-L1) and to evaluate the association of exploratory systemic and/or
tissue-… to HER2 status (A), TMB according to HER2 status (B), correlation between ERBB2 gene

Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer

C Francavilla, CS O'Brien - Open Biology, 2022 - royalsocietypublishing.org
… of breast developmental abnormalities or cancer progression. … co-target, which will be
explored in depth in this review. … subtypes, in addition to available data on the status of the gene

Potential utility of telomere length assessment in breast cancer in a diagnostic histopathology setting.

PL Kong, LM Looi, PL Cheah - Malaysian Journal of …, 2023 - search.ebscohost.com
abnormalities that are non-cancerous and occurs more … variables of breast cancer (age,
histological grade, nodal status)… ERBB2 amplification in breast cancer analyzed by fluorescence …

Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects

T Osako, H Lee, G Turashvili, D Chiu, S McKinney… - Nature Cancer, 2020 - nature.com
… their ER binding site status for the METABRIC expression … ER (ESR1) and HER2 (ERBB2)
subgroups for the METABRIC … this study was an assessment of genetic sources exhibiting age…

Genetics and Oncology (part 2.). Fundamentals of personalised medicine in the treatment of breast and ovarian cancer

A Doraczyńska-Kowalik… - … Journal of Oncology, 2020 - journals.viamedica.pl
… of receptor tyrosine kinase erbB-2 gene (ERBB2 aka HER2). An … Furthermore, HER2 status
should be re-evaluated in post-… breast cancer, as well as for selected cases of specific-type …

Molecular Progression of Breast Cancer and Personalized Medicine in Terms of Clinical Trials

S Liaqat, M Hussain, K Aftab, M Khalid… - Breast Cancer: From …, 2022 - Springer
… For the practical implementation of personalized BC therapies, proper evaluation and … (erbB2)
belongs to the EGFR family of tyrosine kinases and is located on chromosome 17 (17q12). …

PI3K inhibitors in breast cancer therapy

H Ellis, CX Ma - Current oncology reports, 2019 - Springer
… In this review, we will discuss the rationale for targeting PI3K/… common signaling abnormalities
observed in breast cancer, … breast cancer, irrespective of PIK3CA mutation status (median …

The homologous recombination deficiency scar in advanced cancer: agnostic targeting of damaged DNA repair

V Pacheco-Barcia, A Muñoz, E Castro, AI Ballesteros… - Cancers, 2022 - mdpi.com
… In this review, we aim to summarize the roles of HRD across … trial evaluated PARPi efficacy
in early breast cancer after … excluded chromosome 17 because LOH on chromosome 17